TheraB Medical Announces Acquisition by Natus Sensory

TheraB Medical Announces Acquisition by Natus Sensory

TheraB Medical announced on February 11 that it has been acquired by Natus Sensory, an ArchiMed company. TheraB Medical is an East Lansing, Michigan-based innovator in wearable phototherapy technology for neonatal jaundice. Its flagship product, SnugLit, delivers comprehensive body coverage in the familiar form factor of an infant swaddle while eliminating the need for eye protection. Its design allows increased clinician and parent interaction, including breastfeeding, without interrupting therapy. TheraB received FDA 510(k) clearance in January 2026 and is backed by various individual angel investors and funds, including Red Cedar Ventures, Healthcare Equity Angels, Michigan Rise, Gulf... Read More »
DW Healthcare Partners Announces Sale of LKC Technologies to Ametek

DW Healthcare Partners Announces Sale of LKC Technologies to Ametek

DW Healthcare Partners, a healthcare-focused private equity firm, announced on February 3 the sale of LKC Technologies to Ametek, Inc. LKC Technologies will join Ametek as part of its Electronic Instruments Group.  LKC Technologies is a leading provider of technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC Technologies develops portable devices that help doctors test and monitor eye health. These tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss. The company is headquartered in Germantown, Maryland. DW Healthcare Partners previously invested in LKC Technologies in June... Read More »
New Horizon Medical Solutions Acquires Applied Tissue Technologies’ Business Assets

New Horizon Medical Solutions Acquires Applied Tissue Technologies’ Business Assets

Even though we’re approaching the end of the year, the healthcare M&A market hasn’t dried up quite yet. On December 29, New Horizon Medical Solutions (NHMS) announced the acquisition of Applied Tissue Technologies’ (ATT) business assets. The sale of ATT’s assets includes a transparent negative pressure wound therapy device and micro grafting kit. ATT is a 25-year-old wound care company based in Boston, Massachusetts. The company has conducted research and development supported by the United States Department of Defense to help wounded warriors at the point of injury, in instances of prolonged field care and delayed evacuation and throughout advanced levels of military medical... Read More »
Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

On October 20, TPG and Blackstone announced that they entered into a definitive agreement to acquire Hologic, Inc. The purchase represents an enterprise value of up to $18.3 billion.  Founded in 1985, Hologic develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. Hologic reported an annual revenue of more than $4 billion for its 2024 fiscal year, which ended on September 28, 2024.  TPG is a global alternative asset management firm. It was founded in San Francisco in 1992 and has $246 billion of assets under management.  Blackstone is the world’s largest alternative asset manager. The... Read More »
Avanos Medical Bolsters Device Portfolio With Nexus Medical

Avanos Medical Bolsters Device Portfolio With Nexus Medical

On September 15, Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC for an undisclosed price. Nexus Medical is a Lenexa, Kansas-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. Nexus is renowned for its TKO anti-reflux needleless connector technology, which enhances the safety and consistency of nutrition and medication delivery, particularly in high-acuity settings like neonatal and pediatric intensive care units. Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device... Read More »
TheraB Medical Announces Acquisition by Natus Sensory

Keensight Capital Acquires Majority Stake in Isto Biologics

French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of unique bone graft solutions, and includes a range of allografts, which are notably used for bone repair in the spine. Isto sells its products to more than 400 hospitals and clinics, which are used in 15,000 surgical procedures per month, primarily in the United States. Keensight Capital is a European growth buyout firm. With more than 25... Read More »